MOTS — Motus GI Holdings Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$2.64m
- $0.32m
Brief: Motus GI Holdings Says USPTO And EPO Issued Two New Patents For Pure-Vu System
Brief: Motus GI Reports Q3 Loss Per Share Of $0.13
Brief: Motus GI Holdings Receives Notice Of Non-Compliance From Nasdaq
Brief: Motus Gi And Nyu Langone Health Partner To Improve Its Inpatient Colonoscopy Management
Brief: Motus Gi Holdings Files Prospectus Relates To Resale From Time To Time, By Selling Stockholder Of Up To 8.7 Million Shares
Brief: Motus GI Holdings Files Prospectus Relates To Resale By Selling Of Up To 8.7 Mln Common Shares
Brief: Motus GI Expands Intellectual Property Portfolio With Chinese Patent For Its Pure-Vu System
Brief: Armistice Capital Reports 9.6% Passive Stake In Motus Gi Holdings- SEC Filing
Brief: Motus GI Holdings Reports Q2 Loss Per Share Of $0.15
Brief: Motus GI Holdings Reports Q1 Loss Per Share Of $0.23
Brief: Motus GI Holdings Says U.S. Patent & Trademark Office Issued Patent For Co's Flagship Product Pure-Vu System
Brief: Motus GI Gets Israeli Health Ministry Approval For Commercial Sales Of Gen2 Pure-Vu System In Israel
U.S. RESEARCH ROUNDUP- Plantronics, Stericycle, Thomson Reuters
Brief: Motus GI Reports Q4 Loss Per Share $0.21
Brief: Motus GI Receives CE Mark Approval For GEN2 Pure-Vu System
Brief: Motus GI Reports Q3 Loss Per Share $0.18
Brief: Motus GI Announces Expedite Study Initiated By Boston Medical Center To Evaluate Clinical Effectiveness Of Pure-Vu System
Brief: Motus Gi Holdings Q2 Loss Per Share $0.26
Brief: Motus GI Announces Issuance Of New European Patent For The Pure-Vu System